TSW
TNDM icon

Thompson Siegel & Walmsley’s Tandem Diabetes Care TNDM Stock Holding History

Thompson Siegel & Walmsley’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,000
Closed -$190K – 784
2019
Q1 		$190K Buy
+3,000
New +$158K ﹤0.01% 396

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Thompson Siegel & Walmsley's TNDM Position: Q2 2019 in Review

Thompson Siegel & Walmsley sold out of Tandem Diabetes Care (TNDM) in Q2 2019, closing a stake of 3,000 shares — an estimated $190K sold.

Thompson Siegel & Walmsley first reported a position in TNDM in Q1 2019 and held it in 1 quarter. The position peaked at $190K in Q1 2019. 261 funds tracked by Wall St. Rank hold TNDM as of Q2 2019.

  • Thompson Siegel & Walmsley reported no remaining Tandem Diabetes Care position as of Q2 2019 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 3,000 Tandem Diabetes Care shares in Q2 2019, an estimated $190K.
  • Thompson Siegel & Walmsley first reported a position in Tandem Diabetes Care in Q1 2019 and held it in 1 quarter.
  • Thompson Siegel & Walmsley's Tandem Diabetes Care position peaked at $190K in Q1 2019.
  • 261 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2019.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2019, filed 12 Aug 2019.